Literature DB >> 18492700

A novel use of the implantable ventricular assist device for isolated right heart failure.

Satoru Osaki1, Niloo M Edwards, Maryl R Johnson, Takushi Kohmoto.   

Abstract

Isolated right heart failure after cardiac surgery is uncommon and the prognosis remains poor. Additionally, managements for these patients are difficult. Profound postcardiotomy right heart failure developed in a 45-year-old woman after aortic root replacement for critical aortic stenosis with small aortic root. Although maximum medical therapy, intraaortic balloon counterpulsation and extracorporeal membrane oxygenator were attempted, severe right heart failure remained. Finally, an implantable right ventricular assist device (RVAD) was utilized because an immediate myocardial recovery was unlikely. The patient was discharged from the hospital at 17 days after the RVAD implantation. After 79 days of support, right ventricular function had recovered, the fully rehabilitated patient was successfully weaned from the RVAD, and the RVAD was explanted. The patient has no recurrence of heart failure 668 days after RVAD explantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492700     DOI: 10.1510/icvts.2008.180620

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  3 in total

Review 1.  Right side of heart failure.

Authors:  Maya Guglin; Sameer Verma
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  Feasibility and efficacy of bypassing the right ventricle and pulmonary circulation to treat right ventricular failure: an experimental study.

Authors:  Jan Spillner; Christian Stoppe; Nima Hatam; Andrea Amerini; Ares Menon; Christoph Nix; Ulrich Steinseifer; Yousef Abusabha; Hanna Giessen; Rüdiger Autschbach; Marcus Haushofer
Journal:  J Cardiothorac Surg       Date:  2012-02-06       Impact factor: 1.637

3.  Acute-right-ventricular-failure post-cardiotomy: RVAD as a bridge to a successful recovery.

Authors:  F Sertic; A Ali
Journal:  J Surg Case Rep       Date:  2018-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.